DEPTOR

Introduction

Pathway Diagram

flowchart TD
    DEPTOR["DEPTOR<br/>DEP Domain Containing<br/>mTOR Interacting Protein"]
    MTOR["mTOR<br/>Mechanistic Target<br/>of Rapamycin"]
    RICTOR["RICTOR<br/>mTORC2 Component"]
    MLST8["MLST8<br/>mTOR Complex<br/>Component"]
    
    PI3K_AKT["PI3K/AKT<br/>Pathway"]
    AUTOPHAGY["Autophagy<br/>Pathway"]
    OXPHOS["Oxidative<br/>Phosphorylation"]
    
    FIP200["FIP200<br/>Autophagy<br/>Initiator"]
    AMBRA1["AMBRA1<br/>Autophagy<br/>Regulator"]
    PIK3C3["PIK3C3<br/>VPS34<br/>Autophagy Kinase"]
    
    EGFR["EGFR<br/>Growth Factor<br/>Receptor"]
    EGF["EGF<br/>Growth Factor"]
    
    HSPA5["HSPA5<br/>ER Stress<br/>Chaperone"]
    HMGB1["HMGB1<br/>Inflammatory<br/>Mediator"]
    
    ALS["ALS<br/>Amyotrophic<br/>Lateral Sclerosis"]
    MS["Multiple<br/>Sclerosis"]
    NEURODEGENERATION["Neurodegeneration<br/>and Cell Death"]
    
    DEPTOR -->|"inhibits"| MTOR
    MTOR -->|"forms complex with"| RICTOR
    MTOR -->|"forms complex with"| MLST8
    MTOR -->|"regulates"| PI3K_AKT
    MTOR -->|"inhibits"| AUTOPHAGY
    
    PI3K_AKT -->|"promotes"| OXPHOS
    AUTOPHAGY -->|"interacts with"| FIP200
    AUTOPHAGY -->|"interacts with"| AMBRA1
    AUTOPHAGY -->|"requires"| PIK3C3
    
    EGF -->|"activates"| EGFR
    EGFR -->|"activates"| PI3K_AKT
    
    HSPA5 -->|"indicates"| NEURODEGENERATION
    HMGB1 -->|"promotes"| NEURODEGENERATION
    
    DEPTOR -->|"regulates"| ALS
    DEPTOR -->|"associated with"| MS
    OXPHOS -->|"dysfunction leads to"| NEURODEGENERATION
    AUTOPHAGY -->|"dysfunction causes"| NEURODEGENERATION
    
    style DEPTOR fill:#006494
    style AUTOPHAGY fill:#1b5e20
    style PIK3C3 fill:#1b5e20
    style FIP200 fill:#1b5e20
    style AMBRA1 fill:#1b5e20
    style MTOR fill:#4a1a6b
    style RICTOR fill:#4a1a6b
    style PI3K_AKT fill:#4a1a6b
    style ALS fill:#ef5350
    style MS fill:#ef5350
    style NEURODEGENERATION fill:#ef5350
    style HSPA5 fill:#ef5350
    style HMGB1 fill:#ef5350
    style OXPHOS fill:#5d4400

DEPTOR (DEP Domain Containing MTOR Interacting Protein), encoded by the DEPTOR gene (also known as DEPDC1), is an endogenous inhibitor of both mechanistic target of rapamycin complex 1 (mTORC1) and mTORC2. Discovered in 2009, DEPTOR represents a unique node in the mTOR signaling network, functioning as a physiological brake on cell growth and metabolism while paradoxically promoting cell survival in certain cancer contexts.

The DEPTOR protein contains N-terminal DEP (Dishevelled, Egl-10, Pleckstrin) domains and a C-terminal PDZ (Postsynaptic density 95, Discs large, Zonula occludens-1) domain, which mediate its interactions with mTOR and other signaling proteins. Under conditions of nutrient sufficiency, DEPTOR is phosphorylated by mTORC1 and subsequently degraded, releasing the brake on mTOR activity. This dynamic regulation allows cells to respond rapidly to changing environmental conditions.

In the central nervous system, DEPTOR is expressed in neurons and glia, where it plays important roles in regulating autophagy, synaptic plasticity, and cellular stress responses. Dysregulated DEPTOR-mTOR signaling has been implicated in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions, making this pathway a therapeutic target of interest.

Structure and Molecular Mechanism

Gene Organization

The DEPTOR gene spans approximately 40 kb on chromosome 8q24.3 and consists of 11 exons. The coding sequence encodes a protein of 409 amino acids with a molecular weight of approximately 46 kDa. Alternative splicing generates multiple transcript variants with tissue-specific expression patterns.

Protein Domain Architecture

DEPTOR contains several distinctive functional domains:

N-terminal DEP Domains (Residues 1-200)

The N-terminal region contains two DEP domains:

• DEP domain 1 (D1): Residues 1-100

• DEP domain 2 (D2): Residues 100-200

These domains are characteristic of the DEP domain family and mediate:

• Protein-protein interactions

• Membrane association (some DEP domains bind phospholipids)

• Interaction with the mTOR FAT domain

C-terminal PDZ Domain (Residues 300-380)

The PDZ domain at the C-terminus:

• Recognizes C-terminal peptide motifs

• Mediates scaffold formation

• Participates in signaling complex assembly

• Binds to mTOR and other partners

Interdomain Regions

The regions between domains contain:

• Phosphorylation sites (Ser, Thr, Tyr)

• degron sequences for protein degradation

• Intrinsically disordered regions for regulatory interactions

Interaction with mTOR

DEPTOR binds to the FAT (FKBP12-rapamycin associated protein (FRB)-Associated Translocating) domain of mTOR through its DEP domains. This binding sterically inhibits kinase activity:

mTORC1 Inhibition:

• DEPTOR binds to FRB domain

• Prevents substrate access to kinase active site

• Inhibits S6K1 and 4E-BP1 phosphorylation

mTORC2 Inhibition:

• DEPTOR binds to FAT domain

• Blocks AKT phosphorylation at T450

• Reduces AKT signaling output

Regulation of DEPTOR

DEPTOR levels are tightly regulated:

Phosphorylation-Dependent Degradation

• mTORC1 phosphorylates DEPTOR at multiple sites

• Phosphorylation creates degron for SCF-βTrCP recognition

• Polyubiquitination targets DEPTOR for proteasomal degradation

• Nutrient withdrawal stabilizes DEPTOR

Transcriptional Regulation

• mTORC1-S6K1 axis suppresses DEPTOR transcription

• ATF4 and other stress-responsive transcription factors upregulate DEPTOR

• Hypoxia induces DEPTOR expression via HIF-1α

Post-translational Modifications

• Ubiquitination: Multiple lysine residues modified

• Sumoylation: Affects protein stability

• Acetylation: Modulates protein-protein interactions

Biological Functions

mTOR Signaling Regulation

DEPTOR is a central regulator of mTOR signaling:

Negative Regulation of mTORC1

When bound to mTORC1, DEPTOR:

• Inhibits kinase activity toward S6K1 and 4E-BP1

• Prevents phosphorylation of ribosomal protein S6

• Blocks cap-dependent translation

• Reduces cell growth and proliferation

Negative Regulation of mTORC2

DEPTOR also inhibits mTORC2:

• Prevents AKT phosphorylation at T450

• Reduces AKT membrane localization and activation

• Impairs AKT downstream signaling

• Affects cell survival and metabolism

Autophagy Regulation

Through mTOR inhibition, DEPTOR promotes autophagy:

mTORC1-Dependent Autophagy

mTORC1 inhibition releases autophagy inhibition:

• Ulk1 complex activation

• VPS34 complex stimulation

• Autophagosome nucleation

• LC3 lipidation and autophagosome formation

Autophagic Flux Enhancement

DEPTOR enhances autophagic flux:

• Increases lysosomal biogenesis

• Enhances cargo recruitment

• Promotes autophagosome-lysosome fusion

Cellular Metabolism

DEPTOR affects multiple metabolic pathways:

Lipid Metabolism

• Inhibits SREBP-dependent lipogenesis

• Reduces triglyceride synthesis

• Modulates cholesterol homeostasis

Glucose Metabolism

• Reduces AKT-mediated glucose uptake

• Decreases glycolytic rate

• Affects insulin signaling

Mitochondrial Function

• Modulates mitochondrial dynamics

• Affects oxidative phosphorylation

• Regulates mitochondrial biogenesis

Cell Survival and Death

DEPTOR has complex effects on cell survival:

Pro-survival Functions

• Inhibition of mTORC2-AKT promotes apoptosis in some contexts

• However, in cancer cells, DEPTOR can promote survival through:

• Maintained AKT S473 phosphorylation (incomplete inhibition)

• Autophagy activation

• Metabolic reprogramming

Pro-apoptotic Functions

• In certain contexts, DEPTOR promotes apoptosis

• mTORC1 inhibition reduces cell proliferation

• Autophagy过度激活 can lead to cell death

Expression Pattern

Tissue Distribution

DEPTOR is widely expressed with variable levels:

Brain Expression

In the central nervous system, DEPTOR shows:

Regional Distribution:

• Highest in cerebral cortex (layer 5 pyramidal neurons)

• Strong expression in hippocampus (CA1-CA3, dentate gyrus)

• Purkinje cells in cerebellum

• Substantia nigra dopaminergic neurons

• Lower expression in white matter

Cellular Localization:

• Neurons: High expression in soma and dendrites

• Glia: Moderate expression in astrocytes and microglia

• Subcellular: Cytoplasmic and membrane-associated

Developmental Expression:

• Embryonic brain: Moderate expression

• Postnatal: Increasing expression

• Adult: High maintenance in regions of synaptic plasticity

Cellular and Subcellular Distribution

DEPTOR localizes to:

• Cytoplasm: Primary location

• Endoplasmic reticulum: Via PDZ domain interactions

• Golgi apparatus: Partial localization

• Lysosomes: Upon autophagy activation

• Nucleus: Lower levels (non-canonical functions)

Role in Neurodegenerative Diseases

Alzheimer’s Disease

DEPTOR has several connections to Alzheimer’s disease:

mTOR Dysregulation

• mTOR hyperactivation in AD brain

• Reduced DEPTOR expression in AD

• Contributes to translation dysregulation

• Affects synaptic plasticity

Autophagy Impairment

• Impaired autophagic flux in AD

• Reduced DEPTOR limits autophagy activation

• Accumulation of protein aggregates

• Failed clearance of Aβ and tau

Synaptic Dysfunction

• mTOR-mediated synaptic plasticity deficits

• Altered spine morphology

• Memory consolidation impairment

Therapeutic Implications

• Enhancing DEPTOR could restore mTOR balance

• Autophagy activation via DEPTOR

• Reducing Aβ and tau pathology

Parkinson’s Disease

DEPTOR connections to Parkinson’s disease:

mTOR Signaling

• Altered mTOR activity in PD models

• DEPTOR expression changes

• Affects dopaminergic neuron survival

Autophagy and α-Synuclein

• Impaired autophagic clearance of α-synuclein

• DEPTOR enhancement could promote clearance

• Reduced protein aggregation

Mitochondrial Function

• DEPTOR affects mitochondrial dynamics

• PINK1/PARKIN pathway interactions

• Altered mitophagy in PD

Therapeutic Potential

• Neuroprotective effects of DEPTOR

• Autophagy enhancement

• Alpha-synuclein clearance promotion

Other Neurodegenerative Conditions

Huntington’s Disease

• mTOR dysregulation

• Autophagy impairment

• Mutant huntingtin effects

Amyotrophic Lateral Sclerosis (ALS)

• Altered mTOR signaling

• Autophagy defects

• Motor neuron vulnerability

Multiple Sclerosis

• Demyelination processes

• Oligodendrocyte function

• Neuroinflammation modulation

Cancer Associations

DEPTOR has paradoxical roles in cancer:

Overexpression in Cancers

DEPTOR is elevated in:

• Multiple myeloma

• Endometrial cancer

• Thyroid carcinoma

• Certain lymphomas

• Renal cell carcinoma

Oncogenic Functions

Despite being an mTOR inhibitor, DEPTOR promotes cancer:

• Incomplete mTORC2 inhibition

• Maintains AKT S473 phosphorylation

• Autophagy promotes survival

• Metabolic reprogramming

Therapeutic Targeting

Targeting DEPTOR in cancer:

• mTOR inhibitors: Overcome DEPTOR-mediated resistance

• Proteasome inhibitors: Induce DEPTOR accumulation

• Combination strategies

Interaction Network

mTOR Complex Interactions

Downstream Pathways

DEPTOR affects multiple downstream pathways:

mTORC1 Outputs:

• S6K1/2 → Growth, translation

• 4E-BP1 → Translation initiation

• ULK1 → Autophagy (inhibition lifted)

mTORC2 Outputs:

• AKT → Survival, metabolism

• PKCα → Cell polarity

• SGK1 → Ion transport

Signaling Partners

DEPTOR interacts with:

• SCF-βTrCP: For degradation

• PDZ domain proteins: Scaffold functions

• Transcription factors: Transcriptional regulation

Therapeutic Implications

Current Therapeutic Approaches

Targeting the DEPTOR-mTOR axis:

mTOR Inhibitors

• Rapamycin and analogs (rapalogs)

• ATP-competitive inhibitors

• Dual mTORC1/mTORC2 inhibitors

Autophagy Modulators

• Autophagy enhancers (rapamycin, carbamazepine)

• Autophagy inhibitors (chloroquine) in cancer

Combination Strategies

• mTOR inhibitors + autophagy modulators

• Targeted therapy combinations

Emerging Strategies

DEPTOR-Targeting Approaches:

• Gene therapy to increase DEPTOR expression

• Small molecules stabilizing DEPTOR

• Peptide inhibitors of mTOR-DEPTOR interaction

Neurodegeneration-Specific:

• Brain-penetrant mTOR inhibitors

• Autophagy-activating compounds

• Neuroprotective strategies

Challenges

Selectivity:

• mTOR has multiple functions

• Systemic vs. CNS effects

• Cell-type specificity

Safety:

• Immunosuppression risk

• Metabolic side effects

• Tumor-promoting potential

Delivery:

• Blood-brain barrier penetration

• Targeting specific brain regions

• Sustained effect maintenance

Research Directions

Current Knowledge Gaps

• Detailed structural mechanism of DEPTOR inhibition

• Cell-type specific functions in vivo

• Disease-modifying mechanisms

• Biomarkers for therapeutic response

Future Research Priorities

1. Structural studies of DEPTOR-mTOR complex

2. Brain-penetrant mTOR modulators

3. Autophagy enhancers for neurodegeneration

4. Gene therapy approaches

5. Combination therapy strategies

See Also

• mTOR Signaling Pathway

• Autophagy

• Alzheimer’s Disease

• Parkinson’s Disease

• Protein Synthesis

• Synaptic Plasticity

• Cell Growth and Proliferation

• Metabolic Regulation

External Links

• NCBI Gene - DEPTOR

• Ensembl - DEPTOR

• UniProt - DEPTOR

• OMIM - DEPTOR

• GTEx Portal - DEPTOR